Everything we've seen

1. ▣Sep 10, 8:00 PMjournaltime_stop

   Agent 20 — SIR Price/Volume closed long 11 @ $204.23 (+$13.09)

   Time stop: held 94 ≥ 90 days

2. ❖Sep 10, 3:46 PMnewsvia finnhub

   Michael Burry Dumps Nvidia and Palantir Put Options in Fresh Risk Warning

   Burry Pulls the Trigger on Nvidia and Palantir Put Options as Market Risks Rise

3. ?Sep 10, 2:30 PMdecisionconsidered

   Agent 7 — Day Trader — decide: skip

   MOH is up 2.38% intraday with no attributable headline, suggesting institutional flow or sector rotation is driving the move rather than a news-driven spike that might fade on completion. The macro context (5Y5Y forward inflation at 1.6σ above trend) is modestly negative for rate-sensitive sectors, and managed care/health insurers like MOH have some rate sensitivity, which creates a mild headwind. However, with 75 minutes remaining there is reasonable time for continuation, and the absence of a negative catalyst means no obvious reversal trigger. The move is meaningful but not extreme — 2.38% sits at the lower end of the 2-5% range where momentum tends to persist. No reversal signals are evident. On balance, slight lean toward continuation with limited conviction, just clearing the 0.5 threshold given bounded risk parameters.

4. !Sep 10, 2:30 PMsignalseverity 0.02

   Agent 7 — Day Trader — day_trade_skipped

   MOH is up 2.38% intraday with no attributable headline, suggesting institutional flow or sector rotation is driving the move rather than a news-driven spike that might fade on completion. The macro context (5Y5Y forward inflation at 1.6σ above trend) is modestly negative for rate-sensitive sectors, and managed care/health insurers like MOH have some rate sensitivity, which creates a mild headwind. However, with 75 minutes remaining there is reasonable time for continuation, and the absence of a negative catalyst means no obvious reversal trigger. The move is meaningful but not extreme — 2.38% sits at the lower end of the 2-5% range where momentum tends to persist. No reversal signals are evident. On balance, slight lean toward continuation with limited conviction, just clearing the 0.5 threshold given bounded risk parameters.

5. ?Sep 10, 12:30 PMdecisionconsidered

   Agent 7 — Day Trader — decide: skip

   MOH is up 2.84% with 195 minutes remaining — a meaningful move with ample time for continuation. No news headline is attributable, but the absence of news doesn't disqualify the setup; institutional flow or sector rotation could be driving this. The macro context shows 5Y5Y forward inflation (T5YIFR) elevated at 1.6σ above trend, which is modestly negative for rate-sensitive sectors — managed care/insurance names like MOH can be somewhat rate-sensitive, but the headwind is not acute. With no reversal signal indicated and a solid move already established, default momentum bias applies. Probability is modest rather than strong because: (1) no clear catalyst identified, (2) inflation backdrop is slightly adverse for rate-sensitive names, (3) the move is near the lower bound of the 2-5% meaningful-flow range. Overall, a lean toward continuation with a bounded-risk posture is appropriate.

6. !Sep 10, 12:30 PMsignalseverity 0.03

   Agent 7 — Day Trader — day_trade_skipped

   MOH is up 2.84% with 195 minutes remaining — a meaningful move with ample time for continuation. No news headline is attributable, but the absence of news doesn't disqualify the setup; institutional flow or sector rotation could be driving this. The macro context shows 5Y5Y forward inflation (T5YIFR) elevated at 1.6σ above trend, which is modestly negative for rate-sensitive sectors — managed care/insurance names like MOH can be somewhat rate-sensitive, but the headwind is not acute. With no reversal signal indicated and a solid move already established, default momentum bias applies. Probability is modest rather than strong because: (1) no clear catalyst identified, (2) inflation backdrop is slightly adverse for rate-sensitive names, (3) the move is near the lower bound of the 2-5% meaningful-flow range. Overall, a lean toward continuation with a bounded-risk posture is appropriate.

7. ?Sep 10, 10:40 AMdecisionconsidered

   Agent 7 — Day Trader — decide: skip

   MOH is up 2.42% intraday with no attributable headline, suggesting this is flow-driven momentum — likely institutional repositioning or sector rotation. With 305 minutes remaining (well over 5 hours), there is ample time for continuation, which is a meaningful positive. The macro context shows 5Y5Y forward inflation (T5YIFR) elevated at 1.6σ above trend — this is modestly negative for rate-sensitive sectors and could weigh on managed care names like MOH if the market reprices discount rates, but MOH's primary driver is government reimbursement cycles and membership trends rather than pure rate sensitivity. The absence of news is not a disqualifier — the 2.42% move represents real conviction and size. No reversal pattern is evident from the data provided. Balancing the solid intraday momentum and ample time remaining against a mildly unfavorable macro backdrop and no catalyst to sustain narrative-driven buying, this reads as ordinary momentum with no strong reason to fade. Probability set slightly above 0.5 to reflect the net-positive setup without overconfidence.

8. !Sep 10, 10:40 AMsignalseverity 0.02

   Agent 7 — Day Trader — day_trade_skipped

   MOH is up 2.42% intraday with no attributable headline, suggesting this is flow-driven momentum — likely institutional repositioning or sector rotation. With 305 minutes remaining (well over 5 hours), there is ample time for continuation, which is a meaningful positive. The macro context shows 5Y5Y forward inflation (T5YIFR) elevated at 1.6σ above trend — this is modestly negative for rate-sensitive sectors and could weigh on managed care names like MOH if the market reprices discount rates, but MOH's primary driver is government reimbursement cycles and membership trends rather than pure rate sensitivity. The absence of news is not a disqualifier — the 2.42% move represents real conviction and size. No reversal pattern is evident from the data provided. Balancing the solid intraday momentum and ample time remaining against a mildly unfavorable macro backdrop and no catalyst to sustain narrative-driven buying, this reads as ordinary momentum with no strong reason to fade. Probability set slightly above 0.5 to reflect the net-positive setup without overconfidence.

9. ❖Sep 10, 6:02 AMnewsvia finnhub

   Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday

   U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.

10. ❖Sep 9, 11:40 AMnewsvia finnhub

    Michael Burry Sells NVDA, PLTR December 2026 Puts Amid Portfolio-Wide Cuts – Says He’s ‘Pulling Back’ On Risk

    Burry remains short Nvidia and Palantir and still holds 2027 puts on Palantir and QQQ.

11. ❖Sep 8, 3:03 PMnewsvia finnhub

    Health Insurance Providers Stocks Q2 Recap: Benchmarking Molina Healthcare (NYSE:MOH)

    As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Molina Healthcare (NYSE:MOH) and its peers.

12. ?Sep 8, 12:45 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    MOH is down 1.82% intraday with no attributable news catalyst. The move is meaningful but sits just below the 2% threshold where conviction in continuation is stronger. The macro backdrop shows elevated 5-year forward inflation expectations (T5YIFR at 1.7σ above trend), which creates headwinds for rate-sensitive sectors broadly, though managed care (MOH) is not a primary rate-sensitive name — it is more driven by utilization trends, MLR dynamics, and policy. With 180 minutes remaining there is ample time for the move to continue or reverse, which is neutral on the time factor. Absence of news means we cannot attribute the selling to a durable catalyst, but real flow is present. No reversal pattern is evident from the data provided. On balance, momentum is modestly negative with no strong reason to fade it, but also no high-conviction continuation signal. Assigning borderline continuation probability consistent with the system's tiebreak rule.

13. !Sep 8, 12:45 PMsignalseverity -0.02

    Agent 7 — Day Trader — day_trade_skipped

    MOH is down 1.82% intraday with no attributable news catalyst. The move is meaningful but sits just below the 2% threshold where conviction in continuation is stronger. The macro backdrop shows elevated 5-year forward inflation expectations (T5YIFR at 1.7σ above trend), which creates headwinds for rate-sensitive sectors broadly, though managed care (MOH) is not a primary rate-sensitive name — it is more driven by utilization trends, MLR dynamics, and policy. With 180 minutes remaining there is ample time for the move to continue or reverse, which is neutral on the time factor. Absence of news means we cannot attribute the selling to a durable catalyst, but real flow is present. No reversal pattern is evident from the data provided. On balance, momentum is modestly negative with no strong reason to fade it, but also no high-conviction continuation signal. Assigning borderline continuation probability consistent with the system's tiebreak rule.

14. ❖Sep 3, 4:31 AMnewsvia finnhub

    1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

    Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 25.1% over the past six months, topping the S&P 500 by 13.1 percentage points.

15. ❖Sep 2, 2:58 PMnewsvia finnhub

    Oscar Health Membership Surges but Profitability Remains Key

    Oscar Health's membership jumps 46% to 2.96 million, but seasonal enrollment and medical utilization keep profitability in focus.

16. ❖Sep 2, 10:00 AMnewsvia finnhub

    Molina Healthcare Announces Third Quarter 2026 Earnings Release and Conference Call Dates

    LONG BEACH, Calif., September 02, 2026--Molina Healthcare, Inc. (NYSE: MOH) today announced it will issue its earnings release for the third quarter ending September 30, 2026, after the market closes on Wednesday, October 21, 2026, and will host a conference call and webcast to discuss the earnings release on Thursday, October 22, 2026, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 6534841. A telephonic replay of the

17. ?Sep 2, 7:06 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

18. !Sep 2, 7:06 AMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

19. ?Sep 1, 4:23 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

20. !Sep 1, 4:23 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

21. ❖Sep 1, 2:48 PMnewsvia finnhub

    Oscar Health Skyrockets 109% YTD: Time to Bet on the Stock Now?

    Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its price-to-book multiple tops the industry average.

22. ?Sep 1, 12:50 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    MOH is up 2.26% today with no attributable headline, suggesting institutional flow or sector rotation is driving the move. The absence of news does not disqualify continuation — real size moved this stock. Macro context shows elevated 2Y yields (4.34, 2σ above trend), which is modestly negative for managed care valuations via discount rate pressure, but MOH is not a long-duration tech name and the effect is indirect at best. With 175 minutes remaining there is ample time for continuation into the close, so time decay is not a headwind. No reversal pattern is evident from the data provided — the move appears intact. The primary uncertainty is the lack of a clear catalyst, which makes it harder to assess whether the flow is exhausted or ongoing. On balance, momentum is the dominant factor here, and with bounded downside via the -1.5% stop and a fixed profit target, the setup marginally favors continuation. Probability set conservatively at 0.54 reflecting ordinary momentum with no strong confirming or disconfirming evidence beyond the price move itself.

23. !Sep 1, 12:50 PMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    MOH is up 2.26% today with no attributable headline, suggesting institutional flow or sector rotation is driving the move. The absence of news does not disqualify continuation — real size moved this stock. Macro context shows elevated 2Y yields (4.34, 2σ above trend), which is modestly negative for managed care valuations via discount rate pressure, but MOH is not a long-duration tech name and the effect is indirect at best. With 175 minutes remaining there is ample time for continuation into the close, so time decay is not a headwind. No reversal pattern is evident from the data provided — the move appears intact. The primary uncertainty is the lack of a clear catalyst, which makes it harder to assess whether the flow is exhausted or ongoing. On balance, momentum is the dominant factor here, and with bounded downside via the -1.5% stop and a fixed profit target, the setup marginally favors continuation. Probability set conservatively at 0.54 reflecting ordinary momentum with no strong confirming or disconfirming evidence beyond the price move itself.

24. ?Sep 1, 10:46 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    MOH is up 2.22% today with no attributable headline, suggesting institutional flow rather than news-driven buying. The move is meaningful but not extreme, sitting at the lower end of the 2-5% conviction range. Macro context shows elevated 2-year yields (4.34, 2σ above trend), which is a mild headwind for managed care names like MOH insofar as higher rates increase discount rates on earnings and can compress multiples, but the sector is not acutely rate-sensitive compared to banks or long-duration tech. With 300 minutes remaining (essentially a full afternoon session), there is ample time for continuation. The absence of a catalyst is neutral per framework guidance. No reversal pattern or fade signal is evident. The setup is ordinary momentum — no strong reason to expect a fade, no strong accelerant for a sustained push either. Assigning a modest continuation probability above the 0.5 threshold.

25. !Sep 1, 10:46 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    MOH is up 2.22% today with no attributable headline, suggesting institutional flow rather than news-driven buying. The move is meaningful but not extreme, sitting at the lower end of the 2-5% conviction range. Macro context shows elevated 2-year yields (4.34, 2σ above trend), which is a mild headwind for managed care names like MOH insofar as higher rates increase discount rates on earnings and can compress multiples, but the sector is not acutely rate-sensitive compared to banks or long-duration tech. With 300 minutes remaining (essentially a full afternoon session), there is ample time for continuation. The absence of a catalyst is neutral per framework guidance. No reversal pattern or fade signal is evident. The setup is ordinary momentum — no strong reason to expect a fade, no strong accelerant for a sustained push either. Assigning a modest continuation probability above the 0.5 threshold.

26. ?Aug 31, 4:23 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

27. !Aug 31, 4:23 PMsignalseverity 0.15

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

28. ?Aug 31, 3:24 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

29. !Aug 31, 3:24 PMsignalseverity 0.15

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

30. ?Aug 31, 2:24 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

31. !Aug 31, 2:24 PMsignalseverity 0.15

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

32. ❖Aug 31, 1:30 AMnewsvia finnhub

    Michael Burry Bought Beaten-Down Stocks And Shorted AI Favorites — Here’s How His August Bets Fared

    The AI rally put Burry’s bearish stance under pressure as Palantir, CoreWeave, Oracle, Micron, Tesla, Nebius and Nvidia all climbed during August.

33. ?Aug 28, 4:22 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

34. !Aug 28, 4:22 PMsignalseverity 0.14

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

35. ?Aug 28, 3:24 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

36. !Aug 28, 3:24 PMsignalseverity 0.14

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

37. ?Aug 27, 4:22 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

38. !Aug 27, 4:22 PMsignalseverity 0.15

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

39. ?Aug 27, 3:23 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

40. !Aug 27, 3:23 PMsignalseverity 0.15

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

41. ?Aug 27, 2:26 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

42. !Aug 27, 2:26 PMsignalseverity 0.14

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

43. ?Aug 27, 1:26 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

44. !Aug 27, 1:26 PMsignalseverity 0.15

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

45. ?Aug 27, 7:06 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

46. !Aug 27, 7:06 AMsignalseverity 0.17

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

47. ❖Aug 27, 4:06 AMnewsvia finnhub

    The S&P 500's Thanksgiving Leftovers In August 2026

    August 2026 was a good month overall for the Thanksgiving Leftover Stocks of 2025.

48. ?Aug 26, 8:10 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    MOH is down 16.7% from its 30-day high with no clear company-specific negative catalyst visible in the recent news or SEC filings — the lone headline is a neutral historical retrospective, and the 10-Q/8-K filings lack flagged metric deterioration. However, Molina Healthcare operates in the Medicaid managed care space, which faces persistent headwinds from Medicaid redeterminations, state contract renewals, and elevated medical loss ratios across the sector — factors that could be quietly pressuring the stock. The macro backdrop shows 5-year inflation breakevens running 1.6σ above trend, which modestly pressures rate-sensitive equities and adds caution to an otherwise undramatic news environment.

49. !Aug 26, 8:10 PMsignalseverity 0.17

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    MOH is down 16.7% from its 30-day high with no clear company-specific negative catalyst visible in the recent news or SEC filings — the lone headline is a neutral historical retrospective, and the 10-Q/8-K filings lack flagged metric deterioration. However, Molina Healthcare operates in the Medicaid managed care space, which faces persistent headwinds from Medicaid redeterminations, state contract renewals, and elevated medical loss ratios across the sector — factors that could be quietly pressuring the stock. The macro backdrop shows 5-year inflation breakevens running 1.6σ above trend, which modestly pressures rate-sensitive equities and adds caution to an otherwise undramatic news environment.

50. ?Aug 26, 4:22 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

51. !Aug 26, 4:22 PMsignalseverity 0.17

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

52. ?Aug 26, 3:23 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

53. !Aug 26, 3:23 PMsignalseverity 0.16

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

54. ?Aug 26, 2:55 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    MOH is up 2.24% today with no attributable headline, suggesting this is either technical or sector-driven flow. The macro context shows 5Y5Y forward inflation (T5YIFR) elevated at 1.6σ above trend — modestly negative for rate-sensitive sectors including managed care insurers like MOH, as higher long-run inflation expectations can pressure discount rates and compress multiples. However, this headwind is not acute enough to confidently fade a 2.24% move that has likely been building throughout the session. With only 50 minutes remaining until the forced close, there is limited runway for further upside to materialize even if momentum is intact. The absence of news is neutral by framework rules. No reversal pattern is evident from the data provided. Balancing: moderate upside momentum vs. mild macro headwind and compressed time window, this is a borderline continuation read. Probability just above 0.5 reflects ordinary momentum with no strong reason to reverse, but also no strong catalyst to extend meaningfully.

55. !Aug 26, 2:55 PMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    MOH is up 2.24% today with no attributable headline, suggesting this is either technical or sector-driven flow. The macro context shows 5Y5Y forward inflation (T5YIFR) elevated at 1.6σ above trend — modestly negative for rate-sensitive sectors including managed care insurers like MOH, as higher long-run inflation expectations can pressure discount rates and compress multiples. However, this headwind is not acute enough to confidently fade a 2.24% move that has likely been building throughout the session. With only 50 minutes remaining until the forced close, there is limited runway for further upside to materialize even if momentum is intact. The absence of news is neutral by framework rules. No reversal pattern is evident from the data provided. Balancing: moderate upside momentum vs. mild macro headwind and compressed time window, this is a borderline continuation read. Probability just above 0.5 reflects ordinary momentum with no strong reason to reverse, but also no strong catalyst to extend meaningfully.

56. ?Aug 26, 1:35 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    MOH is up ~2% today with no attributable headline, suggesting quiet but real institutional flow. The move is meaningful but not explosive, and the macro context (5Y5Y inflation expectations elevated at 1.6σ above trend) creates a mild headwind for rate-sensitive sectors — managed care/health insurance names like MOH can be indirectly affected through discount rate sensitivity on reserves and premium pricing. However, absence of negative news and the fact that someone with size initiated this move are baseline supportive. With 130 minutes remaining there is ample time for continuation, but without a clear catalyst or sector tailwind, and with a slightly elevated macro concern, this reads as ordinary momentum. Probability sits just above the continuation threshold — the bounded risk profile justifies a modest long lean.

57. !Aug 26, 1:35 PMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    MOH is up ~2% today with no attributable headline, suggesting quiet but real institutional flow. The move is meaningful but not explosive, and the macro context (5Y5Y inflation expectations elevated at 1.6σ above trend) creates a mild headwind for rate-sensitive sectors — managed care/health insurance names like MOH can be indirectly affected through discount rate sensitivity on reserves and premium pricing. However, absence of negative news and the fact that someone with size initiated this move are baseline supportive. With 130 minutes remaining there is ample time for continuation, but without a clear catalyst or sector tailwind, and with a slightly elevated macro concern, this reads as ordinary momentum. Probability sits just above the continuation threshold — the bounded risk profile justifies a modest long lean.

58. ?Aug 26, 1:23 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

59. !Aug 26, 1:23 PMsignalseverity 0.16

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

60. ?Aug 26, 12:23 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

61. !Aug 26, 12:23 PMsignalseverity 0.16

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

62. ?Aug 26, 12:10 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    MOH is up 2.46% with 215 minutes remaining — sufficient time for further move. No headline catalyst is present, but the move itself reflects meaningful institutional flow. The macro context shows 5Y5Y inflation forward (T5YIFR) at 1.6σ above trend, which is mildly unfavorable for rate-sensitive sectors including managed care/insurance names like MOH, as elevated inflation expectations can pressure cost outlooks and discount rates. However, this is a secondary headwind rather than a direct reversal catalyst. With no news to fade and a clean upward move already established, momentum bias leans continuation. The macro overhang keeps conviction modest — this is an ordinary momentum read without clear amplifying factors, so probability sits in the lower portion of the continuation band.

63. !Aug 26, 12:10 PMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    MOH is up 2.46% with 215 minutes remaining — sufficient time for further move. No headline catalyst is present, but the move itself reflects meaningful institutional flow. The macro context shows 5Y5Y inflation forward (T5YIFR) at 1.6σ above trend, which is mildly unfavorable for rate-sensitive sectors including managed care/insurance names like MOH, as elevated inflation expectations can pressure cost outlooks and discount rates. However, this is a secondary headwind rather than a direct reversal catalyst. With no news to fade and a clean upward move already established, momentum bias leans continuation. The macro overhang keeps conviction modest — this is an ordinary momentum read without clear amplifying factors, so probability sits in the lower portion of the continuation band.

64. ?Aug 26, 11:25 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

65. !Aug 26, 11:24 AMsignalseverity 0.16

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

66. ?Aug 26, 10:45 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    MOH is up 2.19% intraday with no attributable headline, suggesting this is likely technical or flow-driven buying. The move is meaningful but not extreme. Macro context shows 5-year forward inflation expectations elevated at 1.6σ above trend — this is a mild headwind for rate-sensitive sectors broadly, but MOH as a managed care name is not particularly rate-sensitive in the traditional sense (more tied to medical cost trends and government program dynamics). No news catalyst means the move could be pure positioning or sector rotation, which can sustain but also fade without a catalyst. With 300 minutes remaining (essentially a full afternoon session), there is ample time for continuation if the underlying flow persists. No reversal signals are noted. Probability is modest above the 0.5 threshold: the move has size behind it, time remains, and there is no compelling reason to expect a fade — but the absence of any news or strong macro tailwind keeps conviction limited.

67. !Aug 26, 10:45 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    MOH is up 2.19% intraday with no attributable headline, suggesting this is likely technical or flow-driven buying. The move is meaningful but not extreme. Macro context shows 5-year forward inflation expectations elevated at 1.6σ above trend — this is a mild headwind for rate-sensitive sectors broadly, but MOH as a managed care name is not particularly rate-sensitive in the traditional sense (more tied to medical cost trends and government program dynamics). No news catalyst means the move could be pure positioning or sector rotation, which can sustain but also fade without a catalyst. With 300 minutes remaining (essentially a full afternoon session), there is ample time for continuation if the underlying flow persists. No reversal signals are noted. Probability is modest above the 0.5 threshold: the move has size behind it, time remains, and there is no compelling reason to expect a fade — but the absence of any news or strong macro tailwind keeps conviction limited.

68. ?Aug 26, 7:05 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

69. !Aug 26, 7:05 AMsignalseverity 0.18

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

70. ?Aug 25, 4:24 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

71. !Aug 25, 4:24 PMsignalseverity 0.18

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

72. ❖Aug 25, 3:45 PMnewsvia finnhub

    Here’s How Much You Would Have Made Owning Molina Healthcare Stock In The Last 20 Years

    Molina Healthcare (NYSE:MOH) has outperformed the market over the past 20 years by 1.81% on an annualized basis producing an average annual return of 11.02%. Currently, Molina Healthcare has a market capitalization of

73. ?Aug 24, 4:24 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

74. ?Aug 24, 12:16 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH (Molina Healthcare) is down 18.7% from its 30-day high — a meaningful but not extreme dip in a Managed Care name. There are no confirming negative catalysts: no alarming headlines, no insider selling, and SEC filings show routine 10-Q/8-K activity with no disclosed metrics indicating fundamental impairment. However, the evidence is thin across the board — no insider cluster buys, no unusual call flow, and no quantitative metrics from filings to anchor a valuation case. Managed Care stocks have faced persistent pressure from Medicaid redeterminations and MLR headwinds in this cycle, and with consensus EPS at only $0.75 for the October 20 earnings print (57 days away, non-imminent), the Street may already be pricing in deterioration. The sector (Health Care / XLV) ranks 4th of 11 in relative strength with slightly negative 30-day momentum vs. SPY, suggesting this is partly sector-driven but not a pure washout.

75. ?Aug 11, 7:03 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

76. ?Aug 10, 6:05 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

77. ?Aug 10, 6:04 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    Molina Healthcare (MOH) is down ~20.4% from its 30-day high with no company-specific negative news headlines in the window and empty metrics in the recent SEC filings, making it difficult to attribute the drop to fundamental deterioration. MOH is a Medicaid-focused managed care insurer — a sector that is recession-sensitive and politically exposed, and the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can signal economic stress and pressure on Medicaid enrollment dynamics or government funding. The lack of any visible catalyst or confirming financial data (metrics: {}) makes this a high-uncertainty situation; the drop may reflect sector-wide managed care headwinds (e.g., Medicaid redeterminations, MLR pressure) rather than company-specific issues, but without confirming data, conviction is limited.

78. ?Aug 10, 7:02 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

79. ?Aug 7, 6:04 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

80. ?Aug 7, 6:04 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    Molina Healthcare (MOH) is down ~20.4% from its 30-day high with no company-specific negative news headlines in the window and empty metrics in the recent SEC filings, making it difficult to attribute the drop to fundamental deterioration. MOH is a Medicaid-focused managed care insurer — a sector that is recession-sensitive and politically exposed, and the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can signal economic stress and pressure on Medicaid enrollment dynamics or government funding. The lack of any visible catalyst or confirming financial data (metrics: {}) makes this a high-uncertainty situation; the drop may reflect sector-wide managed care headwinds (e.g., Medicaid redeterminations, MLR pressure) rather than company-specific issues, but without confirming data, conviction is limited.

81. ?Aug 7, 7:01 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

82. ?Aug 6, 6:04 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

83. ?Aug 6, 6:03 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    Molina Healthcare (MOH) is down ~20.4% from its 30-day high with no company-specific negative news headlines in the window and empty metrics in the recent SEC filings, making it difficult to attribute the drop to fundamental deterioration. MOH is a Medicaid-focused managed care insurer — a sector that is recession-sensitive and politically exposed, and the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can signal economic stress and pressure on Medicaid enrollment dynamics or government funding. The lack of any visible catalyst or confirming financial data (metrics: {}) makes this a high-uncertainty situation; the drop may reflect sector-wide managed care headwinds (e.g., Medicaid redeterminations, MLR pressure) rather than company-specific issues, but without confirming data, conviction is limited.

84. ?Aug 6, 7:02 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

85. ?Aug 5, 6:04 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    Molina Healthcare (MOH) is down ~20.4% from its 30-day high with no company-specific negative news headlines in the window and empty metrics in the recent SEC filings, making it difficult to attribute the drop to fundamental deterioration. MOH is a Medicaid-focused managed care insurer — a sector that is recession-sensitive and politically exposed, and the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can signal economic stress and pressure on Medicaid enrollment dynamics or government funding. The lack of any visible catalyst or confirming financial data (metrics: {}) makes this a high-uncertainty situation; the drop may reflect sector-wide managed care headwinds (e.g., Medicaid redeterminations, MLR pressure) rather than company-specific issues, but without confirming data, conviction is limited.

86. ?Aug 5, 6:04 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

87. ?Aug 5, 7:03 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

88. ?Aug 4, 6:05 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    Molina Healthcare (MOH) is down ~20.4% from its 30-day high with no company-specific negative news headlines in the window and empty metrics in the recent SEC filings, making it difficult to attribute the drop to fundamental deterioration. MOH is a Medicaid-focused managed care insurer — a sector that is recession-sensitive and politically exposed, and the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can signal economic stress and pressure on Medicaid enrollment dynamics or government funding. The lack of any visible catalyst or confirming financial data (metrics: {}) makes this a high-uncertainty situation; the drop may reflect sector-wide managed care headwinds (e.g., Medicaid redeterminations, MLR pressure) rather than company-specific issues, but without confirming data, conviction is limited.

89. ?Aug 4, 6:04 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

90. ?Aug 4, 12:25 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    MOH is down ~2% intraday with no attributable headline, suggesting this is likely flow-driven or sector rotation. The macro context (T5YIE 1.5σ below trend) signals a deflationary/risk-off tilt that could weigh on managed care names like MOH, which tend to be sensitive to rate and inflation expectations. However, the signal is indirect and sectors listed as reactive (Gold, Energy, TIPS) don't include healthcare, so the macro tailwind for continuation is weak. With 200 minutes remaining there is meaningful time for continuation, but the absence of a catalyst makes a clean directional trend into close uncertain. No reversal pattern is evident, and the move magnitude (~2%) is at the lower threshold of meaningful conviction. Net: slight lean toward continuation of the downside move, but confidence is low — probability just clears the 0.5 threshold.

91. ?Aug 4, 7:04 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    MOH is down 20.5% from its 30-day high, which is a meaningful but not extreme drop for a managed care company. The drop is not confirmed by any visible negative catalyst — no news headlines, no SEC filing metrics, and no insider selling activity in the window. The sector (Health Care / XLV) is showing weakness (-3.22pts vs SPY over 5 days) and today's flow proxy is notably negative, suggesting the dip may be partly sector-driven rather than purely idiosyncratic, which is a mild positive for mean-reversion potential. However, earnings are 77 days away with a consensus EPS of just $0.75, which is quite low for a stock trading near $195 — this may reflect analyst uncertainty or a known step-down in profitability, and without accessible financial metrics from the 10-Q, fundamental soundness is assumed but unverified.

92. ?Aug 3, 6:04 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    Molina Healthcare (MOH) is down ~20.4% from its 30-day high with no company-specific negative news headlines in the window and empty metrics in the recent SEC filings, making it difficult to attribute the drop to fundamental deterioration. MOH is a Medicaid-focused managed care insurer — a sector that is recession-sensitive and politically exposed, and the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can signal economic stress and pressure on Medicaid enrollment dynamics or government funding. The lack of any visible catalyst or confirming financial data (metrics: {}) makes this a high-uncertainty situation; the drop may reflect sector-wide managed care headwinds (e.g., Medicaid redeterminations, MLR pressure) rather than company-specific issues, but without confirming data, conviction is limited.

93. ❖Jul 29, 11:52 AMnewsvia finnhub

    UnitedHealth's Cost-Control Story is Gaining Momentum: Time to Buy?

    UNH's improving cost control, lower medical costs and higher 2026 outlook are boosting confidence as its profitability recovery gains traction.

94. ❖Jul 29, 4:25 AMnewsvia finnhub

    Molina Healthcare: Management Has Made The Difficult Decision For Long-Term Benefit

    Molina Healthcare (MOH) is upgraded to Buy with ~20% upside, driven by strategic ACA exit and Medicaid strength.

95. ❖Jul 28, 8:40 PMnewsvia finnhub

    Oakmark Global All Cap Strategy Q2 2026 Portfolio Performance

    The Oakmark Global All Cap Strategy returned 8.05% in Q2 2026, trailing its benchmark due to headwinds in software and media. Read the full analysis for more.

96. ❖Jul 28, 1:59 PMnewsvia finnhub

    Oscar Health Flashes Buy Signal As Medicaid Weighs On Centene

    S&P 500 health insurer Centene blew away Q2 earnings forecasts amid lower-than-expected Affordable Care Act Marketplace benefit costs. Oscar Health, a pure play on the ACA, flashed an early entry buy signal amid Centene's good news and a big price target hike.

97. ❖Jul 28, 11:22 AMnewsvia finnhub

    S&P 500 Stock Centene Dives On Medicaid Outlook

    S&P 500 health insurer Centene blew away Q2 earnings forecasts amid lower-than-expected Affordable Care Act Marketplace benefit costs. CNC stock initially moved higher, but shares reversed sharply lower as the company discussed its outlook, including slightly higher Medicaid attrition and a more costly covered population in the second half of 2026. Centene posted Q2 earnings of $2.51 a share, crushing forecasts of $1.09 by $1.42 a share.

98. ❖Jul 28, 10:18 AMnewsvia finnhub

    Centene Finds Profit Growth Even as Medicaid Membership Softens

    Centene beat Q2 earnings and revenue estimates, raised its 2026 outlook, improved medical cost trends, and reported lower Medicaid membership.

99. ❖Jul 28, 4:59 AMnewsvia finnhub

    Wells Fargo Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $220

    Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Equal-Weight and lowers the price target from $235 to $220.

100. ❖Jul 28, 4:05 AMnewsvia finnhub

     The S&P 500's Thanksgiving Leftovers In July 2026

     July 2026 saw positive changes overall for the Thanksgiving Leftover portfolio made up of the ten worst-performing stocks in the S&P 500 as of Thanksgiving 2025. Read more here...

101. ❖Jul 25, 6:06 AMnewsvia finnhub

     Molina Healthcare (MOH) Plans Big 2027 ACA Pullback After Profit Pressure

     Molina Healthcare (NYSE:MOH) plans to significantly scale back its Affordable Care Act business from 2027. The company intends to limit ACA operations to six states and reduce premiums by a meaningful margin. The move follows ongoing pressure on ACA profitability, including falling membership and higher medical costs. Molina Healthcare, trading at $197.55, is restructuring its portfolio as it responds to challenges in the ACA segment. The stock is up 10.7% year to date and 19.7% over the...

102. ❖Jul 24, 12:39 PMnewsvia finnhub

     Can Humana Beat Q2 Earnings Estimates on Growing Premiums?

     HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.

103. ❖Jul 24, 10:06 AMnewsvia finnhub

     Truist Securities Maintains Hold on Molina Healthcare, Lowers Price Target to $225

     Truist Securities analyst David Macdonald maintains Molina Healthcare (NYSE:MOH) with a Hold and lowers the price target from $250 to $225.

104. ❖Jul 24, 9:40 AMnewsvia finnhub

     Are Investors Undervaluing Molina Healthcare (MOH) Right Now?

     Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

105. ❖Jul 24, 7:06 AMnewsvia finnhub

     RBC Capital Maintains Sector Perform on Molina Healthcare, Lowers Price Target to $218

     RBC Capital analyst Ben Hendrix maintains Molina Healthcare (NYSE:MOH) with a Sector Perform and lowers the price target from $248 to $218.

106. ❖Jul 24, 6:19 AMnewsvia finnhub

     Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $180

     Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $184 to $180.

107. ❖Jul 23, 5:07 PMnewsvia finnhub

     Molina Healthcare Q2 Earnings Call Highlights

     Molina Healthcare (NYSE:MOH) reported second-quarter 2026 adjusted earnings per share of $1.51 on $10.2 billion of premium revenue, with management pointing to steady Medicaid performance and stronger-than-expected Medicare duals results while acknowledging continued pressure in its Marketplace busi

108. ❖Jul 23, 4:30 PMnewsvia finnhub

     Molina Healthcare, Inc. (MOH) Q2 2026 Earnings Call Transcript

     Molina Healthcare, Inc. (MOH) Q2 2026 Earnings Call July 23, 2026 8:00 AM EDTCompany ParticipantsJeffrey Geyer - Head of Investor RelationsJoseph Zubretsky...

109. ❖Jul 23, 3:01 PMnewsvia finnhub

     Molina Healthcare Inc (MOH) Q2 2026 Earnings Call Highlights: Strong Medicaid Performance Amid ...

     Molina Healthcare Inc (MOH) reports robust earnings and revenue growth, but faces hurdles in its Marketplace segment and regulatory pressures.

110. ❖Jul 23, 2:07 PMnewsvia finnhub

     MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised

     Molina beats Q2 earnings estimates as lower operating expenses offset weaker premium revenues, declining membership and softer investment income, while the company raises its 2026 earnings guidance.

111. ❖Jul 23, 9:28 AMnewsvia finnhub

     Molina Healthcare Stung By Membership Decline, Stocks Sinks 12%

     Molina Healthcare (MOH) reported Q2 earnings of $1.51 per share, beating estimates. Shares fell on lower premium revenue and membership.

112. ❖Jul 23, 9:16 AMnewsvia finnhub

     Brent Tops $100, Alphabet, Tesla Sink Nasdaq 100: Stock Market Today

     Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while Alphabet and Tesla earnings revive AI-spending doubts.

113. ❖Jul 23, 8:30 AMnewsvia finnhub

     Molina Healthcare, Inc. Q2 2026 Earnings Call Summary

     Moby summary of Molina Healthcare, Inc.'s Q2 2026 earnings call

114. ❖Jul 23, 7:24 AMnewsvia finnhub

     Molina plans additional ACA cuts in 2027

     Molina’s second quarter was complicated, with stability in Medicaid and outperformance in Medicare Advantage overshadowed by problems in the ACA exchanges. The trend was “unfortunate,” according to the insurer’s CEO.

115. ❖Jul 23, 6:34 AMnewsvia finnhub

     Molina Healthcare shares fall after weak revenue outlook overshadows earnings beat (NYSE:MOH)

     Molina Healthcare (NYSE:MOH) shares dropped more than 9% in premarket trading on Thursday after the health insurer issued a full-year revenue outlook that disappointed investors, despite reporting second-quarter earnings ahead of market expectations. While profitability exceeded forecasts, concerns over slowing revenue growth and ongoing Medicaid headwinds weighed heavily on market sentiment.

116. ❖Jul 23, 4:03 AMnewsvia finnhub

     Rollins Posts Downbeat Q2 Earnings, Joins Texas Instruments, Alphabet And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

     Stock futures down on Thursday, Rollins Inc (ROL) reports disappointing Q2 results, other stocks also decline in pre-market trading.

117. ▢Jul 22, 8:00 PMjournal

     Agent 7 — Day Trader opened short 14 @ $207.59

118. ▣Jul 22, 8:00 PMjournaltarget

     Agent 7 — Day Trader closed short 14 @ $201.22 (+$89.18)

     Short target: close $201.22 ≤ target $201.36

119. ❖Jul 22, 6:35 PMnewsvia finnhub

     Molina Healthcare Earnings Beat Estimates. The Medicaid Insurer Is Confronting Investor Doubts.

     Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.

120. ❖Jul 22, 6:30 PMnewsvia finnhub

     Here's What Key Metrics Tell Us About Molina (MOH) Q2 Earnings

     The headline numbers for Molina (MOH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

121. ❖Jul 22, 5:55 PMnewsvia finnhub

     Molina (MOH) Q2 Earnings Top Estimates

     Molina (MOH) delivered earnings and revenue surprises of +10.22% and -0.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

122. ❖Jul 22, 5:03 PMnewsvia finnhub

     Molina Healthcare (NYSE:MOH) Surprises on Q2 Earnings, Raises Guidance as Quality Stock Nears Trough in Medicaid Cycle

     Molina Healthcare beat Q2 earnings estimates and raised full-year adjusted guidance to at least $5.25 per share, signaling a potential trough in the Medicaid cycle.

123. ❖Jul 22, 4:41 PMnewsvia finnhub

     Molina Healthcare (NYSE:MOH) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops On Weak Guidance

     Healthcare insurance company Molina Healthcare (NYSE:MOH) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 4.8% year on year to $10.87 billion. On the other hand, the company’s full-year revenue guidance of $42 billion at the midpoint came in 5.1% below analysts’ estimates. Its non-GAAP profit of $1.51 per share was 7.8% above analysts’ consensus estimates.

124. ❖Jul 22, 4:15 PMnewsvia finnhub

     Molina Healthcare Reports Second Quarter 2026 Financial Results

     LONG BEACH, Calif., July 22, 2026--Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today reported second quarter 2026 GAAP income per diluted share of $1.19 and adjusted income per diluted share of $1.51. Financial results are summarized below:

125. ❖Jul 22, 1:05 PMnewsvia finnhub

     12 Health Care Stocks Moving In Wednesday's After-Market Session

     Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday's after-market session. The market value of their outstanding shares is at $135.0 million. Medpace Holdings

126. ❖Jul 22, 12:17 PMnewsvia finnhub

     Molina Healthcare Q2 Adj. EPS $1.51 Beats $1.39 Estimate, Sales $10.874B Beat $10.794B Estimate

     Molina Healthcare (NYSE:MOH) reported quarterly earnings of $1.51 per share which beat the analyst consensus estimate of $1.39 by 8.63 percent. This is a 72.45 percent decrease over earnings of $5.48 per share from the

127. ❖Jul 22, 12:16 PMnewsvia finnhub

     Molina Healthcare sees FY2026 GAAP EPS expected to be more than $2.15 vs $2.60 Est

     Molina Healthcare (NYSE:MOH) FY2026 gaap eps expected to be more than $2.15 vs $2.60 Est..

128. ❖Jul 22, 12:16 PMnewsvia finnhub

     Molina Healthcare sees FY2026 Adj EPS expected to be more than $5.25 vs $5.15 Est

     Molina Healthcare (NYSE:MOH) FY2026 expected to be more than $5.25 vs $5.15 Est..

129. ❖Jul 22, 11:41 AMnewsvia finnhub

     Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates

     CNC reports Q2 results July 28 as investors weigh improving profitability against membership declines and revenue pressure ahead of earnings.

130. ❖Jul 22, 3:11 AMnewsvia finnhub

     Earnings Scheduled For July 22, 2026

     Companies Reporting Before The Bell • Northern Trust (NASDAQ:NTRS) is expected to report quarterly earnings at $3.45 per share on revenue of $2.35 billion. • Old National Bancorp (NASDAQ:ONB) is projected to report

131. ❖Jul 21, 9:15 AMnewsvia finnhub

     Exploring Analyst Estimates for Molina (MOH) Q2 Earnings, Beyond Revenue and EPS

     Beyond analysts' top-and-bottom-line estimates for Molina (MOH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

132. ❖Jul 21, 5:34 AMnewsvia finnhub

     Molina Healthcare (MOH) To Report Earnings Tomorrow: Here Is What To Expect

     Healthcare insurance company Molina Healthcare (NYSE:MOH) will be reporting results this Wednesday after market close. Here’s what investors should know.

133. ❖Jul 19, 12:50 AMnewsvia finnhub

     Molina Healthcare: The Market Has The Story Backwards

     Molina Healthcare rated Hold: 2027 recovery looks priced in. Click for more on MOH stock prospects.

134. ▢Jun 8, 8:00 PMjournal

     Agent 20 — SIR Price/Volume opened long 11 @ $203.04